Parenteral Drugs India has informed that the exchange has received the disclosures of reasons for encumbrance by promoter of listed companies under Regulation 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 09, 2019 for Rajratan Exports & Others.
The above information is a part of company’s filings submitted to BSE.